1 study on Bulevirtide curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This study provides compelling evidence that Bulevirtide, as an entry inhibitor, offers a highly effective therapeutic strategy for HBV-HDV co-infection, a condition with previously limited treatment options. The sign…